التفاصيل البيبلوغرافية
| العنوان: |
Distant survival for patients undergoing surgery using volatile versus IV anesthesia for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study. |
| المؤلفون: |
Meng, Xiao-Yan, Zhang, Xiu-Ping, Sun, Zhe, Wang, Hong-Qian, Yu, Wei-Feng |
| المصدر: |
BMC Anesthesiology; 9/14/2020, Vol. 20 Issue 1, pN.PAG-N.PAG, 1p |
| مصطلحات موضوعية: |
PORTAL vein surgery, CANCER patients, CANCER relapse, COMPARATIVE studies, CONFIDENCE intervals, HEPATOCELLULAR carcinoma, INHALATION anesthesia, INTRAVENOUS anesthesia, LONGITUDINAL method, PATIENTS, PORTAL vein, RISK assessment, SURGERY, SURGICAL complications, TREATMENT effectiveness, PROPORTIONAL hazards models, RETROSPECTIVE studies, SEVERITY of illness index, DESCRIPTIVE statistics, DISEASE risk factors |
| مصطلحات جغرافية: |
CHINA |
| مستخلص: |
Background: Whether anesthesia type is associated with the surgical outcome of Hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) remains to be determined. This study aims to investigate the impact of volatile inhalational anesthesia (INHA) versus total IV anesthesia (TIVA) on the survival outcomes in HCC patients with PVTT. Methods: A cohort of in-patients whom were diagnosed of HCC with PVTT in Eastern Hepatobiliary Surgery Hospital, Shanghai, China, from January 1, 2008 to December 24, 2012 were identified. Surgical patients receiving the INHA and TIVA were screened out. The overall survival (OS), recurrence-free survival (RFS) and several postoperative adverse events were compared according to anesthesia types. Results: A total of 1513 patients were included in this study. After exclusions are applied, 263 patients remain in the INHA group and 208 in the TIVA group. Patients receiving INHA have a lower 5-year overall survival rate than that of patients receiving TIVA [12.6% (95% CI, 9.0 to 17.3) vs. 17.7% (95% CI, 11.3 to 20.8), P = 0.024]. Results of multivariable Cox-regression analysis also identify that INHA anesthesia is significantly associated with mortality and cancer recurrence after surgery compare to TIVA, with HR (95%CI) of 1.303 (1.065, 1.595) and 1.265 (1.040, 1.539), respectively. Subgroup analysis suggested that in more severe cancer patients, the worse outcome related to INHA might be more significant. Conclusion: This retrospective analysis identifies that TIVA is associated with better outcomes compared with INHA. Future prospective studies clinical and translational studies are required to verify this difference and investigate underlying pathophysiology. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Anesthesiology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder